KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Sales (2016 - 2025)

West Pharmaceutical Services' Return on Sales history spans 17 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, down 1.0%, while the annual FY2025 figure was 0.16%, 1.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.16% at West Pharmaceutical Services, down from 0.17% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.25% in Q2 2021 and bottomed at 0.12% in Q1 2025.
  • The 5-year median for Return on Sales is 0.18% (2023), against an average of 0.19%.
  • The largest annual shift saw Return on Sales grew 10bps in 2021 before it decreased -7bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.2% in 2021, then tumbled by -30bps to 0.14% in 2022, then rose by 30bps to 0.18% in 2023, then decreased by -6bps to 0.17% in 2024, then fell by -7bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for WST's Return on Sales are 0.16% (Q4 2025), 0.17% (Q3 2025), and 0.17% (Q2 2025).